Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 27Terminated 5Withdrawn 2Recruiting 2Unknown 1No longer available 1

Sponsor Class

INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Non-Hodgkin 2Leukemia, Myeloid, Acute 2Neoplasms, Plasma Cell 1Multiple Myeloma 1Lymphoma 1Hodgkin Disease 1Autologous Stem Cell Transplantation 1

Interventions

Dexamethasone 64Cyclophosphamide 40Bortezomib 37Melphalan 24Lenalidomide 23Thalidomide 17pomalidomide 16fludarabine 12daratumumab 11carfilzomib 10Filgrastim 8Doxorubicin 8Busulfan 6Prednisone 5Peripheral Blood Stem Cell Transplantation 5Bendamustine Hydrochloride 5selinexor 4sargramostim 4isatuximab 4fludarabine phosphate 4Surveys and Questionnaires 4Etoposide 4Clarithromycin 4Calcium Dobesilate 4liposomal doxorubicin 3ixazomib 3Radiotherapy 3Neoadjuvant Therapy 3Mycophenolic Acid 3Methylprednisolone 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Multiple Myeloma × plerixafor × Clear all
NCT01042717 2011-09-27

Study of the Best Timing for Plerixafor in Autologous Hematopoietic Stem Cell Collection

Shi, Patricia, M.D.

Phase NA Unknown
10 enrolled
LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡